Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Liang

Showing results (601-610 of 619) with videos related to

Pageof 62
Sort By:
The Lancet. Gastroenterology & Hepatology|November 30, 2025
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trialZheng Wang, Lixing Li, Peiran Huang, et al.
Stem Cell Reviews and Reports|September 20, 2025
Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone RegenerationZi-Qi Zhang, Yuan Yuan, Xiao-Hui Zhang, et al.
BJS Open|November 5, 2025
Impact of external drainage of the main pancreatic duct and common bile duct on postoperative pancreatic fistula following pancreatoduodenectomy: protocol for a multicentre randomized clinical trialWen-Quan Wang, Yao-Lin Xu, Lin-Hui Tang, et al.
Annals of Surgery|November 20, 2020
Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-center, Randomized Controlled TrialDexiang Zhu, Jianguo Xia, Yan Gu, et al.
Science China. Life Sciences|July 11, 2025
Androgen induces 3'UTR shortening of de novo lipogenesis genes by alternative polyadenylation in prostate cancer cellsWei-Jie Sun, Fei Liang, Hui Zhao, et al.
Journal of Hepatology|November 18, 2021
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinomaGuang-Yu Ding, Jia-Qiang Ma, Jing-Ping Yun, et al.
The Lancet. Oncology|September 1, 2025
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 studyGuoming Shi, Xiaoyong Huang, Xiaowu Li, et al.
Advanced Healthcare Materials|May 16, 2025
Development-Inspired Biomimetic Cell-Niche Coaggregates Safeguard Tooth Stem Cell-Based Functional Tissue RegenerationXiao-Hui Zhang, Yi-De He, Hao Wang, et al.
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trialZheng Wang, Jia Fan, Shaolai Zhou, et al.
Cancer Letters|January 12, 2025
RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIsXinjun Tang, Jie Hu, Renhua Guo, et al.
Pageof 62

Showing results (601-610 of 619) with videos related to

Sort By:
Pageof 62
The Lancet. Gastroenterology & Hepatology|November 30, 2025
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trialZheng Wang, Lixing Li, Peiran Huang, et al.
Stem Cell Reviews and Reports|September 20, 2025
Recipient Periodic Fasting Promotes Osteogenesis of Implanted Mesenchymal Stromal Cell Aggregates and Safeguards Diabetic Mandibular Bone RegenerationZi-Qi Zhang, Yuan Yuan, Xiao-Hui Zhang, et al.
BJS Open|November 5, 2025
Impact of external drainage of the main pancreatic duct and common bile duct on postoperative pancreatic fistula following pancreatoduodenectomy: protocol for a multicentre randomized clinical trialWen-Quan Wang, Yao-Lin Xu, Lin-Hui Tang, et al.
Annals of Surgery|November 20, 2020
Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-center, Randomized Controlled TrialDexiang Zhu, Jianguo Xia, Yan Gu, et al.
Science China. Life Sciences|July 11, 2025
Androgen induces 3'UTR shortening of de novo lipogenesis genes by alternative polyadenylation in prostate cancer cellsWei-Jie Sun, Fei Liang, Hui Zhao, et al.
Journal of Hepatology|November 18, 2021
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinomaGuang-Yu Ding, Jia-Qiang Ma, Jing-Ping Yun, et al.
The Lancet. Oncology|September 1, 2025
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 studyGuoming Shi, Xiaoyong Huang, Xiaowu Li, et al.
Advanced Healthcare Materials|May 16, 2025
Development-Inspired Biomimetic Cell-Niche Coaggregates Safeguard Tooth Stem Cell-Based Functional Tissue RegenerationXiao-Hui Zhang, Yi-De He, Hao Wang, et al.
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trialZheng Wang, Jia Fan, Shaolai Zhou, et al.
Cancer Letters|January 12, 2025
RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIsXinjun Tang, Jie Hu, Renhua Guo, et al.
Pageof 62